Pharmacokinetic Characterization of Intramuscular Olanzapine Depot
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The goals of this study are to:
Determine the blood levels of intramuscular (IM) olanzapine depot in patients at different
points in time after an injection, and compare these levels to the amount of olanzapine in
the blood of patients after treated by oral administration with Zyprexa (olanzapine) tablets
or by intramuscular administration with Zyprexa IntraMuscular (olanzapine for injection).